Venacore

Company Overview

Snapshot

Founded in April 2019, Venacore operates with 1–10 employees. The company has secured funding across one round from Med Venture Holdings to advance its medical device technology.

Business overview

Venacore is a medical device company specializing in structural intervention occluders for cardiology. The company develops devices designed for the closure of congenital heart defects, specifically engineered to anchor and occlude effectively in large vessels where conventional plugs may not perform adequately. Venacore operates within the Health Tech & Life Sciences sector, focusing on medical devices and medical treatment & therapeutics, primarily serving healthcare providers.

Company Intelligence Q&A

What is Venacore's primary focus?

Venacore is a medical device company developing a structural intervention occluder for the closure of congenital heart defects, designed for effective anchoring and occlusion in large vessels.

When was Venacore founded?

Venacore was founded in April 2019.

Which investor participated in Venacore's funding round?

In May 2019, Med Venture Holdings participated as a lead investor in Venacore's funding round.

What stage is Venacore currently in?

Venacore is currently in the Seed stage, with its product in the R&D phase.

What market does Venacore target?

Venacore targets the healthcare market, specifically providers, with its medical devices for cardiology.